CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
TUESDAY 06 SEPTEMBER, 2016
11:45
The omics approach to defining endotypes and personalising treatment pathways in asthma
Sally Wenzel (Pittsburgh, United States of America)
3479
12:15
The future of personalised medicine in COPD
Alvar Agusti Garcia-Navarro (Barcelona, Spain)
Room A Session 554 10:45 - 12:45
Symposium: Childhood wheeze: are we making any progress?
Aims : The aim of this session is to discuss the progress in the management of preschool wheezing; describe the importance of the basics
right for childhood asthma management; detail the modern approaches to phenotyping; and discuss future strategies for modifying the
disease.
Track(s) : Paediatric
Tag(s) : Translational
Target audience : Allied health professional, General practitioner, Junior member, Nurse, Paediatrician, Patient, Physiotherapist,
Psychologist, Student
Chairs : Gunilla Hedlin (Stockholm, Sweden), Sejal Saglani (London, United Kingdom)
3480
10:45
11:15
11:45
Eosinophils are out of fashion: the only way forward is to target the neutrophils
Avraham Beigelman (Washington, United States of America)
Asthma diagnosis and monitoring: do we have anything useful in addition to history and examination?
Karin C. Lodrup Carlsen (Oslo, Norway)
Translational approaches to decipher mechanisms: does innate immunity affect disease onset or
persistence?
Bianca Schaub (Germering, Germany)
3481
3482
3483
12:15
Future directions: preventing and treating asthma
Jonathan Grigg (London, United Kingdom)
Room B Session 555 10:45 - 12:45
Symposium: Microbiome in health and in disease
Aims : The aim of this session is to give participants insight in the latest developments related to environmental and respiratory
microbiome research, in particular focussed on the respiratory microbiome.
Track(s) : Epidemiology / Environment Infection
Tag(s) : Basic science
Target audience : Allied health professional, Clinician, Epidemiologist, Fellow, Immunologist, Microbiologist, Paediatrician, Public
health official, Researcher, Respiratory physician, Scientist, Student
Chairs : Ruby Pawankar (Tokyo, Japan), Oliver Eickelberg (Munich, Germany)
3484
10:45
11:15
11:45
Effect of the microbiome on early life
Erika von Mutius (Munich, Germany)
Microbiome and early origins of lung disease
Debby Bogaert (Utrecht, Netherlands)
The airway microbiota: a key regulator of homeostasis and fibrosis
Eric Bernasconi (Lausanne, Switzerland)
3485
3486
3487
12:15
Gut microbiome in COPD
Philip Hansbro (Callaghan, Australia)
Platinum Room 1+2 Session 556 10:45 - 12:45
Symposium: Hypoxia, the carotid body, and the brain
Aims : The carotid body is a small organ of great physiological importance because it is the main sensor of hypoxia in the body. New data
suggest that the carotid body plays a complex role in the modulation of sympathetic activity in response to not only hypoxia but also
metabolic stimuli. This session will discuss the clinical implications of the most recent research, with special emphasis on the role of the
carotid body in patients with sleep-disordered breathing. This session will also expand our understanding of the consequences of impaired
blood gases in the brain in patients with respiratory diseases. The audience will leave the session with a better understanding of the
mechanisms that underlie the functional handicaps of respiratory patients, and the new opportunities in treatment and patient management.
3488
232 26.08.2016